SA
RMTI icon

Scarborough Advisors’s Rockwell Medical RMTI Stock Holding History

Scarborough Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27
Closed -$240 – 561
2026
Q1 		$240 Buy
+27
New +$269 ﹤0.01% 697
2024
Q1 		– Sell
-27
Closed -$508 – 647
2023
Q4 		$508 Buy
+27
New +$507 ﹤0.01% 660

Other funds holding RMTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Scarborough Advisors's RMTI Position: Q2 2026 in Review

Scarborough Advisors sold out of Rockwell Medical (RMTI) in Q2 2026, closing a stake of 27 shares — an estimated $240 sold.

Scarborough Advisors first reported a position in RMTI in Q4 2023 and held it in 2 quarters. The position peaked at $508 in Q4 2023. 37 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

  • Scarborough Advisors reported no remaining Rockwell Medical position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 27 Rockwell Medical shares in Q2 2026, an estimated $240.
  • Scarborough Advisors first reported a position in Rockwell Medical in Q4 2023 and held it in 2 quarters.
  • Scarborough Advisors's Rockwell Medical position peaked at $508 in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.